Registration is officially OPEN for the 2024 DTRF Together We Will Weekend and RFA Walk. - Register Now

The Desmoid Tumor Research Foundation

April 2015

Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.

Author Information

Eiji Kozawa,Hiroshi Urakawa,Kunihiro Ikuta,Naoki Ishiguro,Satoshi Tsukushi,Shunsuke Hamada,Yoshihiro Nishida,Yuichi Ando

Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, 65-Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan,ynishida@med.nagoya-u.ac.jp.

Publication

Summary

MTX and VBL treatment every other week is well tolerated and achieved a favorable response in patients resistant to meloxicam treatment, regardless of CTNNB1 mutation status.

View Abstract